STUDYING OF TUMOR NECROSIS FACTOR and INTERLEUKIN RECEPTORS expression in hepatic TISSUE of ANIMALS PROTRACTEDLY RECEIVING NIMESULIDE

Abstract

Aim. To study the immunohistochemical expression of TNFαR1 and IL-2Rα in hepatic tissue of animals (rats) with modeled NSAID-associated hepatitis. Materials and methods. The study of TNFαR1 and IL-2Rα in the hepatic tissue of experimental animals was carried out using antibodies TNFR1 (poly) 100 μl, bs-2941R, Rabbit Anti-TNF Receptor I Polyclonal Antibody (Bioss) and IL-2Rα (poly) 1 ml (М-19), sc-666 (Santa Cruz Biotechnology, INC), antibodies species-specific to rat tissue antigens. To reveal the antibodies, Uno Vue detection system, 100 tests, UMR 100PD, object-plates with polylysine coating Menzel were applied. The study was performed using the hepatic tissue of animal of experimental groups, who were administered nimesulide (Naiz®) during 21 days in the following doses: 0,5 mg/kg (therapeutic dose) ( n = 25); 2,5 mg/kg ( n = 20); 5 mg/kg ( n = 24). Intact animals ( n = 21) were used as the control. Antigen-positive cells were identified by the appearance of brown staining while examining preparations at light-optic level. The results of this reaction were assessed with semiquantitative method - in “crosses” (in connection with markers localization on the cellular membrane) and by the number of positively stained cells - in scores. Manifestation of markers expression was evaluated “in crosses” when successively examining the fields of vision under the microscope (from 10 to 20 in each histological section); according to the intensity of staining, the fields of vision were attributed to 4 groups: with negative reaction (-), weakly positive (+), positive (++) and distinctly positive (+++). The markers expression was assessed by a six-score system: 2 scores - up to 20% of stained cells; 4 scores - from 20 to 40 % of stained cells; 6 scores - more than 40 % of stained cells. Results. When studying immunohistochemical expression of TNFαR1in the hepatic tissue of rats with modeled NSAID-associated hepatitis, in all experimental groups there was observed immunopositiveness of the liver parenchyma and that of some cells of portal tract bile-ducts epithelium. Thus, when using nimesulide for a long time, the readiness of liver parenchyma epithelial cells to apoptosis, conditioned by the action of tumor necrosis factor, was stated. Conclusions. There was observed IL-2Rα expression in the liver parenchyma and in a part of bile-ducts of portal tracts among animals of all experimental groups that can be explained by the presence of autoimmune processes. Elevated TNFαR1 and IL-2Rα expression in the liver tissue was noted in animals of experimental group, who received a fivefold dose of nimesulide. Decreased expression of receptors in animals, who took a tenfold dose, can be associated with extensive necroses in the liver parenchyma.

Keywords

Nonsteroid anti-inflammatory drugs / NSAID-hepatopathy / nimesulide / TNFαR1expression / IL-2Rα expression

References

[1] Барановский А.Ю., Марченко Н.В., Мительглик У.А., Райхельсон К.Л. Роль фактора некроза опухоли альфа в развитии аутоиммунной патологии печени: нерешенная проблема. Практическая медицина 2014; 1 (77): 15-19.

[2] Жолобова Е.С., Конопелько О.Ю., Гешева З.В. Гепатотоксичность нестероидных противовоспалительных препаратов, применяемых в детской ревматологии. Педиатрия 2009; 88 (5): 155-160.

[3] Козлова И.В., Липатова Т.Е., Афонина Н.Г., Кветной И.М. Гастропатия, индуцированная нестероидными противовоспалительными препаратами, у больных остеоартрозом: роль некоторых факторов диффузной эндокринной системы желудка в ее возникновении. Российский журнал гастроэнтерологии, гепатологии, колонопроктологии 2006; 1: 47-53.

[4] Ключарева А.А. Лекарственный гепатит. Медицинские новости 2012; 12: 25-32.

[5] Коган Е.А., Низяева Н.В., Демура Т.А. Автономность роста очагов аденомиоза: иммуногистохимические особенности экспрессии маркеров. Иммунология 2011; 12: 311-325.

[6] Муравьев Ю.В. Гепатотоксичны ли НПВП? Научно-практическая ревматология 2002; 4: 36-41.

[7] Полунина Т.Е., Маев И.В. Клиника, диагностика и коррекция острого лекарственного гепатита. Лечащий врач 2007; 1: 48-52.

[8] Федотова А.П., Чибыева Л.П., Васильев Н.Н. Гастродуоденальные эрозивно-язвенные повреждения, индуцированные приемом нестероидных противовоспалительных препаратов, в условиях Республики Саха. Якутский медицинский журнал 2010; 31 (3): 24-27.

[9] Циммерман Я.С. Клиническая гастроэнтерология: избранные разделы. М.: ГЭОТАР-Медиа 2009; 416.

[10] Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol. 2010; 16 (45): 5651-5661.

[11] Boelsterli U.A. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf 2002; 25: 633-648.

[12] Bort R., Ponsoda X., Jover R. Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. Pharmacol Exp Ther 1999; 288: 65-72.

[13] Cantoni L., Valaperta R., Ponsoda X. Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity. Hepatol 2003; 238 (6): 776-783.

[14] Doi H., Horie T. Salicylic acid-induced hepatotoxicity triggered by oxidative stress. Chem Biol Interact 2010; 183: 363-368.

[15] Gomez-Lechon M.J., Ponsoda X., O’Connor E., Donato T., Castell J.V., Jover R. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem Pharmacol 2003; 66: 2155-2167.

[16] Greaves R.R., Agarwal A., Patch D. Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure. Eur J Gastroenterol Hepatol 2001; 13: 71-73.

[17] Hartel C., von Puttkamer J., Gallner F., Strunk T., Schultz C. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Scand J Immunol 2004; 60: 412-420.

[18] Inigues M., Punzon C., Fresno M. Induction of Cyclooxygenase-2 on activated t lymphocytes: regulation of t cell activation by cyclooxygenase-2 inhibitors. J Immunol 1999; 163: 111-119.

[19] Modi C.M., Mody S.K., Patel H.B., Dudhatra G.B., Kumar A., Avale M. Toxicopathological overview of analgesic and anti-inflammatory drugs in animals. Journal of Applied Pharmaceutical Science 2012; 02 (01): 149-157.

[20] O'Connor N., Dargan P.I., Jones A.L. Hepatocellular damage from non-steroidal anti-inflammatory drugs. Q J Med 2003; 96: 787-791.

[21] Paccani S.R., Boncristiano M., Ulivieri C., D'Elios M.M., Del Prete G., Baldari C.T. Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J Biol Chem 2002; 277:1509-1513.

[22] Scully L.J., Clarke D., Barr R.J. Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 1993; 38 (4): 744-751.

[23] Tang W. The metabolism of diclofenac-enzymology and toxicology perspectives. Curr Drug Metab 2003; 4: 319-329.

[24] Tian G., Yu J.P., Luo H.S., Yu B.P., Yue H., Li J.Y. Effect of Nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells. World J Gastroenterol 2002; 8: 483-487.

RIGHTS & PERMISSIONS

Lazarenko L.V., Kosareva P.V., Samodelkin E.I., Khorinko V.P.